Should you buy Rivian stock while it's still below $15?
Show Caption
Hide Caption
Experiencing a Rivian electric joyride at SXSW 2025
Check out Rivian offering an off-roading experience in downtown Austin, Texas.
Fox - 7 Austin
Few companies have survived the boom and bust of the electric vehicle sector in the last five years. Rivian Automotive (NASDAQ: RIVN) is one that is still kicking. Along with Tesla, it is one of the only pure-play electric vehicle (EV) companies left producing cars for customers as competition intensifies and industry growth subsides.
The company is still in the very early stages, but has big plans for its product pipeline and investments in the coming years. As of this writing, the stock trades below $15, which is down over 90% from all-time highs set back at its initial public offering. At such a discounted price, is now the time to invest in EV disrupter Rivian Automotive? Let's dig into its Q1 earnings and investigate further.
Lowered deliveries guidance
With demand for EVs slowing to a crawl in 2025, Rivian's deliveries to customers have hit a wall. Its R1 truck costs $70,000-$100,000 for individuals to purchase, making it too expensive for most shoppers in the United States. Deliveries were just 8,640 last quarter, which is a fraction of the deliveries for industry leaders such as Tesla. This figure is moving in the wrong direction, with deliveries of over 13,000 in the first quarter a year ago.
However, Rivian is making progress to improve its unit economics and free-cash burn. Its gross margin hit a positive 17% in Q1, a record for the company. This came because of increasing revenue from software and services to $318 million compared to $88 million a year ago, along with payments from its joint venture with Volkswagen. Free cash flow over the last 12 months was negative $1.8 billion, an improvement from a few years ago.
With $7 billion in cash on the balance sheet and billions of dollars in promised funding from partners like Volkswagen along with the United States government, Rivian Automotive has plenty of years left to try to get to positive free cash flow. In order to do so, it will need to start growing its deliveries again to get to scale. How does it plan to do that? With a cheaper EV model.
Upcoming R2 vehicle
The R2 is an SUV that Rivian is planning to release in 2026, with factory production getting built right now. It will cost around $45,000-$50,000, significantly decreasing the price point compared to the R1. This should open up the market for more people in the United States to try a Rivian vehicle.
Even though Rivian is a niche player in the space, it already has the best-selling premium SUV costing over $70,000 in California, one of the largest markets for EVs. The brand is strong and customers are happy with its product quality. If it can get to scale, reduce prices, and still keep this premium brand for customers, Rivian could see an acceleration in demand for its vehicles in 2026 and beyond. It will need to do so in order to reach positive cash flow.
Should you buy Rivian stock?
Rivian is generating exactly $5 billion in annual revenue right now. If it can scale up production with the cheaper R2 and get deliveries moving in the right direction, there is plenty of opportunity to grow this revenue figure to $10 billion, $20 billion, and possibly even higher throughout the rest of the decade. There are over a million EVs sold in the United States every year, a number that should grow over the long term.
Having $20 billion in revenue with increasing gross margins could help Rivian turn around its financials. At a market capitalization of $16 billion right now, even just $1 billion in positive free-cash-flow generation at some point in the near future could help turn the corner for Rivian stock.
The problem is, the company has a lot of work ahead to make this happen. It has not shown yet that it can get deliveries moving in the right direction and is making a huge bet on the R2 product. Competition is coming from legacy automotive players that keep gaining share in the United States. It will need to grow deliveries by a significant amount in order to reach large enough scale to flip to positive free cash flow. Gross margins in the automotive business are slim, and you need to get enough unit volumes in order to cover your overhead costs.
When taking all of this into consideration, it is hard to argue why someone should own Rivian stock right now. There is a lot of potential with this brand, but it has not proven it can generate positive free cash flow or has a clear path to growing deliveries. For now, stay away from Rivian stock even at its cheap-looking price today.
Brett Schafer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool recommends Volkswagen Ag. The Motley Fool has a disclosure policy.
The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY.
Should you invest $1,000 in Rivian Automotive right now?
Offer from the Motley Fool: Before you buy stock in Rivian Automotive, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rivian Automotive wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider whenNetflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation,you'd have $614,911!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation,you'd have $714,958!*
Now, it's worth notingStock Advisor's total average return is907% — a market-crushing outperformance compared to163%for the S&P 500. Don't miss out on the latest top 10 list, available when you joinStock Advisor.
See the 10 stocks »

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
12 minutes ago
- Business Wire
Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced its bitXbio (pronounced 'bit by bio') Plan, a next-generation capitalization and monetization public-market strategy integrating Bitcoin (BTC) in support of its biotech commercialization efforts. The initiative will be anchored by a Bitcoin-backed treasury strategy that was recently approved by its board of directors, aimed at expanding Aditxt's capital ecosystem and aligning its enterprise value (EV) with projected monetization opportunities starting in 2026. Aditxt is a social innovation platform that currently operates two programs focused on autoimmunity and early disease and cancer detection. The Company seeks to grow by A cquiring, B uilding, and C apitalizing high-growth ventures across health and biotechnology. The bitXbio Plan marks a deliberate move to broaden the company's capital accessibility and align its current market value with its commercialization roadmap — blending Bitcoin-backed reserve with capital access to support scale and liquidity. 'bitXbio™ is a forward-looking strategy designed to align our capital structure with the value-creation potential of our biotech pipeline,' said Amro Albanna, Co-founder and CEO of Aditxt. 'As we look to strengthen our balance sheet and enterprise value, we plan to seek to integrate digital currency reserves, subject to the availability of funds, and continue to utilize our equity line to support the commercialization of high-impact innovations. We believe that this approach positions us to unlock shareholder value as we strive to execute on planned monetization milestones, starting in 2026.' Plan Highlights Bitcoin-Backed Treasury Strategy Aditxt plans to establish a Bitcoin reserve, subject to the availability of funds, to align its market value in support of its commercialization activities, and to unlock a new class of opportunities with digital asset economies. Equity Line Facility Aditxt intends to strategically deploy capital drawn on its existing equity line facility to meet its existing financial obligations and in support of its commercialization roadmap and upcoming monetization events. Aditxt has approximately $125 million in availability under its common stock purchase agreement with its equity line investor, of which it presently has the ability to sell up to 50 million shares of its common stock pursuant to its registration statement on Form S-1, which was declared effective by the SEC on June 30, 2025. Planned Capitalization Events in 2026 As part of its 2026 monetization strategy, Aditxt is positioning Pearsanta for an initial public offering. The plan reflects Aditxt's broader vision to build a global, socially driven biotech platform, capable of commercializing and monetizing innovation through digital capitalization. About Aditxt, Inc. Aditxt, Inc. is a social innovation platform accelerating promising health innovations. Aditxt's ecosystem of research institutions, industry partners, and shareholders collaboratively drives their mission to "Make Promising Innovations Possible Together." The innovation platform is the cornerstone of Aditxt's strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder's voice is heard and valued, and empowers collective progress. The Company currently operates two programs focused on immune health and precision health. Through the proposed acquisition of Evofem under the July 2024 Amended and Restated Merger Agreement between Evofem, Aditxt and Adifem, Inc., as amended (the "A&R Merger Agreement"), Aditxt aims to introduce an additional program dedicated to women's health. The companies are working toward a targeted close in the second half of 2025. The closing of the transaction with Evofem is subject to several conditions, including but not limited to approval of the transaction by Evofem's shareholders and Aditxt raising sufficient capital to fund its obligations at closing. These obligations include cash payments of approximately $17 million for Evofem, which includes approximately $15.2 million required to satisfy Evofem's senior secured noteholder; should Aditxt fail to secure these funds, Evofem's senior secured noteholder is expected to seek to prevent the closing of the merger with Evofem. No assurance can be provided that all of the conditions to closing will be obtained or satisfied or that the transaction will ultimately close. Forward-Looking Statements This press release includes "forward-looking statements," within the meaning of the safe harbor for forward-looking statements provided by Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Words such as, but not limited to, "achieving," "advancing," "aim," "are working to," "believe," "completing," "continue," "could," "design," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "seek," "should," "suggest," "strategy," "target," "will," "would," and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements include but are not limited to anticipated availability of funds to pursue the purchase of digital assets; expected growth of Aditxt; Aditxt's ability to successfully execute its mission to accelerate and monetize promising health innovations, and magnitude thereof; Aditxt's ability to complete the proposed initial public offering of Pearsanta on the proposed timeline, if at all; and Aditxt's ability to close the planned acquisition of Evofem, including to meet all closing conditions, and the timing thereof. You are cautioned not to place undue reliance on these forward-looking statements, which are current only as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Important factors that could cause actual results to differ materially from those discussed or implied in the forward-looking statements are disclosed in each company's SEC filings, including Aditxt's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 21, 2025, and any subsequent Form 10-Q filings. All forward-looking statements are expressly qualified in their entirety by such factors. Aditxt undertakes no duty to update any forward-looking statement except as required by law. For more information, please visit bitXbio™ is a trademark of Aditxt, Inc. All rights reserved. Follow Aditxt on:


Business Wire
23 minutes ago
- Business Wire
Evolv Technology to Release Second Quarter Financial Results on August 14, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the second quarter of 2025 on Thursday, August 14, 2025, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at About Evolv Technology Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than two billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal's (SBJ) 2024 awards for 'Best In Fan Experience Technology' and 'Best In Sports Technology'. Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit


Business Wire
23 minutes ago
- Business Wire
NiCE Actimize 2025 Fraud Insights Report Shows Scams Still the Method of Choice in Attempted Fraud Transactions
BUSINESS WIRE)-- NiCE Actimize, a NiCE (NASDAQ: NICE) business, has released the "2025 NiCE Actimize Fraud Insights Report, U.S. Retail Payments Edition," which explores the latest findings on the evolution of fraud attacks across various transaction types, including check fraud, domestic and international wires, and Zelle payments. Utilizing NiCE Actimize's collective intelligence and Federated Learning, the Fraud Insights report was developed by analyzing billions of banking and payments transactions. According to the report, from 2023 to 2024, fraudsters' focus shifted back slightly towards Account Takeover (ATO) Fraud from Scams, in terms of the overall value of attempts. Scams are still the method of choice across 57% of attempted fraud transactions; however, ATO fraud is showing no sign of disappearing. From a volume perspective, there was a slight shift towards Scams to 52% in 2024 vs. 50/50 split in 2023. In the U.S., the top fraud challenges vary significantly depending on whether the focus is on value (dollar amount of the transactions) or volume (number of transactions), the report says. The most notable development since last year's report, concerns international wires. In 2024, the total value of international wire transactions declined 6% year over year, but the value of attempted fraud for international wires surged 40%. Additionally, Zelle transactions saw a 26% increase in value, accompanied by a 34% rise in attempted fraud. The report's data also revealed that 67% of all fraud is linked to just 7% of payments made to newly added payees—highlighting how fraudsters are exploiting when a new recipient is introduced into the payment flow. 'Industry collaboration is more crucial than ever. Sharing knowledge, expertise, and data helps us establish effective controls to safeguard financial institutions and their customers,' said Craig Costigan, CEO of NiCE Actimize. 'With our decades of experience, we've developed solutions that go beyond payments and by leveraging advanced AI, we've improved model building and operational efficiency for comprehensive protection at every stage. The fraud management community has a strong history of innovation, a value that we at NiCE Actimize have embedded at the very core of our organization.' The report also highlights that international wire fraud attempts are becoming more targeted and sophisticated, often involving social engineering tactics and mule accounts across borders. Financial institutions are seeing a rise in fraud rings exploiting weak onboarding controls in cross-border payment systems, making international wires a growing area of concern despite their relatively low transaction volume. The report's statistics also show that fraudsters are strategically targeting different payment types based on their characteristics—high-value fraud through checks and wires, and high-frequency, lower-value fraud through faster digital channels like Zelle. This underscores the need for channel-specific fraud prevention strategies. Addressing the Surge In Fraud With the increase in both the volume and complexity of scams, as the research reports, NiCE Actimize offers a comprehensive suite of solutions to help financial institutions stay ahead of these emerging threats. One such innovation is IFM Advanced Scam Prevention, which leverages machine learning and collective intelligence gathered from NiCE Actimize's extensive global client network. This solution is specifically designed to detect and prevent scams—currently the most prevalent fraud typology—by analyzing behavioral patterns, identifying suspicious counterparties, and sharing intelligence across institutions. By combining real-time analytics with a deep understanding of scam tactics, IFM Advanced Scam Prevention empowers organizations to proactively block fraudulent transactions before they occur. To download a copy of NiCE Actimize's 2025 Fraud Insights report, please click here. About NiCE Actimize As a global leader in artificial intelligence, platform services, and cloud solutions, NiCE Actimize excels in preventing fraud, detecting financial crime, and supporting regulatory compliance. Over 1,000 organizations across more than 70 countries trust NiCE Actimize to protect their institutions and safeguard assets throughout the entire customer lifecycle. With NiCE Actimize, customers gain deeper insights and mitigate risks. Learn more at About NiCE NiCE (NASDAQ: NICE) is transforming the world with AI that puts people first. Our purpose-built AI-powered platforms automate engagements into proactive, safe, intelligent actions, empowering individuals and organizations to innovate and act, from interaction to resolution. Trusted by organizations throughout 150+ countries worldwide, NiCE's platforms are widely adopted across industries connecting people, systems, and workflows to work smarter at scale, elevating performance across the organization, delivering proven measurable outcomes. Trademark Note: NiCE and the NiCE logo are trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE's marks, please see: Forward-Looking Statements This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Costigan, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the 'Company'). In some cases, such forward-looking statements can be identified by terms such as 'believe,' 'expect,' 'seek,' 'may,' 'will,' 'intend,' 'should,' 'project,' 'anticipate,' 'plan,' 'estimate,' or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in general economic and business conditions; competition; successful execution of the Company's growth strategy; success and growth of the Company's cloud Software-as-a-Service business; rapid changes in technology and market requirements; the implementation of AI capabilities in certain products and services, decline in demand for the Company's products; inability to timely develop and introduce new technologies, products and applications; difficulties in making additional acquisitions or difficulties or effectively integrating acquired operations; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company's dependency on third-party cloud computing platform providers, hosting facilities and service partners; cyber security attacks or other security incidents; privacy concerns; changes in currency exchange rates and interest rates, the effects of additional tax liabilities resulting from our global operations, the effect of unexpected events or geo-political conditions, including those arising from political instability or armed conflict that may disrupt our business and the global economy; our ability to recruit and retain qualified personnel; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the 'SEC'). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company's reports filed from time to time with the SEC, including the Company's Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.